Brief: Aytu Biopharma Announces Approval Of Cotempla XR-ODT Manufacturing Site Transfer Prior Approval Supplement
26/10/2023 13:56
Oct 26 (Reuters) - Aytu Biopharma Inc AYTU.O :
* AYTU BIOPHARMA ANNOUNCES APPROVAL OF COTEMPLA XR-ODT
MANUFACTURING SITE TRANSFER PRIOR APPROVAL SUPPLEMENT
* AYTU BIOPHARMA INC: EXPECTS TO BEGIN INITIAL RAMP-UP OF
CONTRACT
MANUFACTURING OF ADZENYS AND COTEMPLA IN LATE CALENDAR 2023
Source text for Eikon: ID:
Further company coverage: AYTU.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Aytu Biopharma
See all newsAytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales
Aytu Biopharma Inc expected to post a loss of 32 cents a share - Earnings Preview
Aytu BioPharma Q3 revenue falls amid EXXUA launch
Aytu BioPharma Q2 revenue beats expectations